Tenax Therapeutics (TENX) Share-based Compensation (2010 - 2026)
Tenax Therapeutics (TENX) posted quarterly Share-based Compensation of $23.9 million for Q2 2026, up 431.11% year-over-year from $4.5 million in Q2 2025, and down 9.81% on a QoQ basis from $26.5 million in Q1 2026.
Tenax Therapeutics (TENX) Share-based Compensation (2010 - 2026) Analysis & Trends
Tenax Therapeutics has reported Share-based Compensation for 15 years, with the latest figure at $23.9 million in Q2 2026.
- Share-based Compensation for Q2 2026 came in at $23.9 million, up 431.11% year-over-year; the trailing twelve-month figure through Jun 2026 was $23.9 million (up 148.41% YoY), and the FY2025 annual result was $19.2 million, up 25.25% from the prior year.
- Share-based Compensation eased to $23.9 million in Q2 2026, from $26.5 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $26.5 million in Q1 2026 and troughed at $9000.0 in Q3 2024.
- A 3-year average of $8.3 million and a median of $4.3 million in 2025 frame the typical range for Share-based Compensation.
- The largest YoY upside for Share-based Compensation was 204344.44% in 2025 against a maximum downside of 393.81% in 2025.
- A 3-year view of Share-based Compensation shows it stood at $970000.0 in 2024, then surged by 393.81% to $4.8 million in 2025, then soared by 398.96% to $23.9 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $23.9 million in Q2 2026, $26.5 million in Q1 2026, and $4.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Tenax Therapeutics | 80.73 Mn | 80.73 Mn | - | 23.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.90 Mn |
| Jun 30, 2026 | 23.90 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 26.50 Mn |
| Jun 30, 2025 | 26.50 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 965,000.00 |
| Dec 31, 2024 | 965,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |